Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion type Assertion NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_head.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion description "[Abnormal HER2 activation, either through HER2 overexpression or heregulin (HRG):HER3 binding, elicits the formation of potent HER2-HER3 heterodimers and drives breast cancer cell growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_provenance.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion evidence source_evidence_literature NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_provenance.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion SIO_000772 23378579 NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_provenance.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion wasDerivedFrom befree-20150227 NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_provenance.
- NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_assertion wasGeneratedBy ECO_0000203 NP380530.RAR3tVw1OzaZ26Cunx0jdHetaQx_0y5-_F0a45KOYzqyQ130_provenance.